Chinese Academy of Sciences — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Chinese Academy of Sciences appears in 38 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials38

Recruiting shown3

Roles2

SourceClinicalTrials.gov

Clinical trials

38 shown

Protein Supplementation Intervention on Body WeightNCT06989203 · lead sponsor · 2025-06-10

Probiotic Intervention on Body WeightNCT06989177 · lead sponsor · 2025-06-10

Energy Metabolism Profiles Over Weight-loss and Eating ResponsesNCT05785221 · lead sponsor · 2023-03-02

ACTIVE_NOT_RECRUITING

Lifestyle Intervention Trial in High Metabolic Risk ChineseNCT04714723 · lead sponsor · 2020-12-27

Classification of Benign and Malignant Lung Nodules Based on CT Raw DataNCT04241614 · lead sponsor · 2019-04-15

Dietary Pattern and Metabolic Health StudyNCT03856762 · lead sponsor · 2019-03-01

Radiomics of Mp-MRI Assessing NAC Outcome in Breast CancerNCT03592004 · lead sponsor · 2018-07-18

The Intervention Study of Dietary Intake on Energy ExpenditureNCT03231618 · lead sponsor · 2017-09-01

Sentinel Lymph Node Biopsy in Breast Cancer Surgery Using ICGNCT03579979 · lead sponsor · 2017-08-24

Safety and Efficacy Study of Human ESC-derived Neural Precursor Cells in the Treatment of Parkinson's DiseaseNCT03119636 · lead sponsor · 2017-05-01

Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With DiabetesNCT02745808 · lead sponsor · 2015-09-01

Study on Dietary Nutrition Intervention Techniques for Children ObesityNCT02539836 · lead sponsor · 2015-09-01

NIR Fluorescence Imaging Technique in Thoracic Surgery With ICGNCT02611245 · lead sponsor · 2015-08-01

Therapeutic Resistance Prediction of Tyrosine Kinase InhibitorsNCT02851329 · lead sponsor · 2015-02-01

Application of Surgical Navigation System in Sentinel Lymph Node of Breast Cancer ResearchNCT02084784 · lead sponsor · 2014-01-01

Acupuncture Study on Rheumatoid Arthritis, Monitoring Microbiome and BloodNCT01619176 · lead sponsor · 2012-10-01

Low-Carbohydrate Diet Intervention on Body WeightNCT01358890 · lead sponsor · 2011-05-01

The Association of Fast Food Densities With Mortality From Cardiovascular DiseaseNCT03243253 · lead sponsor · 2011-01-01

Brown Rice Intervention on Metabolic Syndrome (BRIMS)NCT01022411 · lead sponsor · 2009-10-01

Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung CancerNCT00576914 · lead sponsor · 2007-06-01

The Potential Effects and Mechanisms of Flax Lignans on Type 2 Diabetes MellitusNCT00363233 · lead sponsor · 2006-03-01

The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's DiseaseNCT07457125 · collaborator · 2026-05-30

tDCS Combined With rTMS for Negative Symptoms of SchizophreniaNCT05695144 · collaborator · 2022-07-01

Association Between Persistent Organic Pollutants and Type 2 Diabetes /Thyroid CancerNCT05218395 · collaborator · 2021-12-20

Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st ChemotherapyNCT04985201 · collaborator · 2021-11-01

Efficacy and Safety of Bifidobacterium Quadruple Live Tablets in Patients With T2DM and ConstipationNCT04982380 · collaborator · 2021-07-31

Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st ChemotherapyNCT04698941 · collaborator · 2021-07-25

Observational Study of ASCVD Risks of Type 2 Diabetes in East ChinaNCT04866667 · collaborator · 2021-05-01

Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic AgentsNCT04287387 · collaborator · 2020-03-02

High-Definition Transcranial Direct Current Stimulation as a Treatment of Negative Symptoms of SchizophreniaNCT03602716 · collaborator · 2018-10-16

Matching Glaucoma With Impaired CognitionNCT03695224 · collaborator · 2018-10-08

Effects of Oxytocin on Negative Symptoms and Social Cognition in Schizophrenia and Its Possible MechanismsNCT03662425 · collaborator · 2018-07-21

Dopaminergic Mechanism of Memory Impairment in Parkinson's DiseaseNCT04968613 · collaborator · 2018-01-01

Artificial Intelligence-assissted Glaucoma EvaluationNCT03268031 · collaborator · 2017-08-15

Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological CharacteristicsNCT03219008 · collaborator · 2017-08-01

Multi-center Imaging Genetics Studies in ChinaNCT02681822 · collaborator · 2015-11-01

Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With DiabetesNCT02579148 · collaborator · 2015-09-01

The Imaging Genetic Study of Schizophrenia and FamilyNCT01259232 · collaborator · 2011-09-01

Drugs studied in this sponsor's trials

14 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Chinese Academy of Sciences as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

indocyanine green3

methylene blue2

semaglutide2

simvastatin2

acarbose Oral Tablet1

fluoxetine1

fluvoxamine1

glimepiride Oral Tablet1

indocyanine green RxCUI 5775 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials methylene blue RxCUI 6878 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials semaglutide RxCUI 1991302 · Lead sponsor in 2 linked trial(s) · 2 currently recruiting 2 trials simvastatin RxCUI 36567 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials acarbose Oral Tablet RxCUI 370504 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial fluoxetine RxCUI 4493 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial fluvoxamine RxCUI 42355 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial glimepiride Oral Tablet RxCUI 372319 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial irinotecan RxCUI 51499 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial leflunomide RxCUI 27169 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial levodopa RxCUI 6375 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial methotrexate RxCUI 6851 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial oxytocin RxCUI 7824 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial pioglitazone Oral Tablet RxCUI 374606 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor21

collaborator17

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.